- Home
- LDWY vs BDRX Comparison
LDWY vs BDRX Comparison
Compare LDWY & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.40
HOLD
Current Price
$2.62
Company Overview
Basic Information| Metric | LDWY | BDRX |
|---|---|---|
| Founded | 1990 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2M | 4.0M |
| IPO Year | 1991 | N/A |
Fundamental Metrics
Financial Performance| Metric | LDWY | BDRX |
|---|---|---|
| Price | $3.40 | $2.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 54.3K | ★ 2.6M |
| Earning Date | 11-10-2025 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $69,769,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.04 | ★ N/A |
| Revenue Growth | ★ 121.91 | N/A |
| 52 Week Low | $3.11 | $2.83 |
| 52 Week High | $6.19 | $92.00 |
Technical Indicators
Market Signals| Indicator | LDWY | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 42.68 | 38.99 |
| Support Level | $3.20 | $4.55 |
| Resistance Level | $3.45 | $7.22 |
| Average True Range (ATR) | 0.30 | 1.49 |
| MACD | 0.03 | -0.28 |
| Stochastic Oscillator | 17.26 | 1.25 |
Price Performance
Historical Comparison LDWY
BDRX
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in industries: Specialty Ag, consisting of the Bloomia business.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.